Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Expands By 125.0%

As of February 28th, 2025, the short interest in the Fidelity Disruptive Medicine ETF (NASDAQ:FMED) has seen a significant increase. The short interest has risen by 125.0%, reaching a total of 900 shares compared to just 400 shares on February 13th. This increase indicates that a small fraction of the fund's shares is currently sold short, approximately 0.0%. With an average daily trading volume of 5,700 shares, the short-interest ratio stands at 0.2 days.

Institutional Trading Activity

In a recent move, Jane Street Group LLC has significantly boosted its holdings in the Fidelity Disruptive Medicine ETF. According to the latest 13F filing with the Securities and Exchange Commission, the institutional investor raised its position by 200.4% during the third quarter, acquiring an additional 40,924 shares. As a result, Jane Street Group LLC now owns 61,342 shares of FMED, representing about 2.92% of the ETF with a value estimated at $1,613,000 as of the end of the reporting period.

Current Stock Performance

FMED started trading at $24.03 on a recent Friday, showcasing a 12-month low of $23.32 and a high of $26.79. The ETF's fifty-day simple moving average sits at $25.50, while the 200-day simple moving average is at $25.70. The market capitalization of the Fidelity Disruptive Medicine ETF is valued at approximately $50.46 million, with a P/E ratio of 42.34 and a beta of 0.94.

Dividend Announcement

Recently, the Fidelity Disruptive Medicine ETF announced a quarterly dividend, which was paid on December 24th. Shareholders on record as of December 20th received a dividend of $0.112. The ex-dividend date was also set for December 20th. This dividend yields an annualized amount of $0.45, which translates to a dividend yield of 1.86%. This is a notable increase from the ETF’s previous dividend of $0.00.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an actively managed exchange-traded fund primarily focused on health care equity. It is geared toward companies involved in disruptive technological innovations in the health care sector. The fund invests in both domestic and international securities and was launched on April 16, 2020.

ETF, short, shares, dividend, stocks